• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Rottapharm SpA - Product Pipeline Review - Q1 2011 Product Image

Rottapharm SpA - Product Pipeline Review - Q1 2011

  • ID: 1801331
  • April 2011
  • 66 pages
  • Global Markets Direct

Rottapharm SpA – Product Pipeline Review – Q1 2011

Summary

Global Market Direct’s pharmaceuticals report, “Rottapharm SpA - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Rottapharm SpA - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Rottapharm SpA human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the READ MORE >



List of Tables
List of Figures
Rottapharm SpA Snapshot
Rottapharm SpA Overview
Key Information
Key Facts
Rottapharm SpA – Research and Development Overview
Key Therapeutic Areas
Rottapharm SpA – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Rottapharm SpA – Pipeline Products Glance
Rottapharm SpA – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Rottapharm SpA Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Rottapharm SpA–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Rottapharm SpA – Drug Profiles
Dexloxiglumide
Product Description
Mechanism of Action
R&D Progress
Megestrol Acetate
Product Description
Mechanism of Action
R&D Progress
Dexloxiglumide
Product Description
Mechanism of Action
R&D Progress
Itriglumide
Product Description
Mechanism of Action
R&D Progress
Megestrol Acetate
Product Description
Mechanism of Action
R&D Progress
CR 3465
Product Description
Mechanism of Action
R&D Progress
Legalon SIL
Product Description
Mechanism of Action
R&D Progress
Plantago Ovata Husk
Product Description
Mechanism of Action
R&D Progress
4-oxo-fenretinide
Product Description
Mechanism of Action
R&D Progress
CR 2991
Product Description
Mechanism of Action
R&D Progress
CR 3394
Product Description
Mechanism of Action
R&D Progress
CR 3465
Product Description
Mechanism of Action
R&D Progress
CR 3663 Series
Product Description
Mechanism of Action
R&D Progress
CR 3719 Series
Product Description
Mechanism of Action
R&D Progress
CR 3834
Product Description
Mechanism of Action
R&D Progress
CR 4056
Product Description
Mechanism of Action
R&D Progress
CR 4144 Series
Product Description
Mechanism of Action
R&D Progress
CR 4152 Series
Product Description
Mechanism of Action
R&D Progress
CR 4153 Series
Product Description
Mechanism of Action
R&D Progress
CR 4167 Series
Product Description
Mechanism of Action
R&D Progress
BRU 83-92
Product Description
Mechanism of Action
R&D Progress
CR 3663 Series
Product Description
Mechanism of Action
R&D Progress
CR 4174 Series
Product Description
Mechanism of Action
R&D Progress
CR 4892 Series
Product Description
Mechanism of Action
R&D Progress
CR 5259 Series
Product Description
Mechanism of Action
R&D Progress
CR 5542 Series
Product Description
Mechanism of Action
R&D Progress
CR 5790 Series
Product Description
Mechanism of Action
R&D Progress
CRB 0016
Product Description
Mechanism of Action
R&D Progress
Rottapharm SpA – Pipeline Analysis
Rottapharm SpA – Pipeline Products by Therapeutic Class
Rottapharm SpA - Pipeline Products By Target
Rottapharm SpA – Pipeline Products by Route of Administration
Rottapharm SpA – Pipeline Products by Molecule Type
Rottapharm SpA – Recent Pipeline Updates
Rottapharm SpA - Dormant Projects
Rottapharm SpA - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
CR 2991
Rottapharm SpA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Financial Deals Landscape
Rottapharm SpA, Deals Summary, 2004 to 2011
Rottapharm SpA Detailed Deal Summary
Speciality European Pharma Enters Into Co-Marketing Agreement With Rottapharm
Licensing Agreements
Indevus And Rottapharm Enters Into Licensing Agreement With Allergan
Rottapharm Enters Into Licensing Agreement With Xytis
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Rottapharm SpA – Pipeline by Therapy Area and Indication, 2011
Rottapharm SpA – Pipeline by Stage of Development, 2011
Rottapharm SpA – Monotherapy Products in Pipeline, 2011
Rottapharm SpA – Phase III, 2011
Rottapharm SpA - Phase II, 2011
Rottapharm SpA - Phase I, 2011
Rottapharm SpA - Pipeline By Therapeutic Class, 2011
Rottapharm SpA - Pipeline By Target, 2011
Rottapharm SpA – Pipeline By Route of Administration, 2011
Rottapharm SpA – Pipeline By Molecule Type, 2011
Rottapharm SpA – Recent Pipeline Updates, 2011
Rottapharm SpA - Dormant Developmental Projects, 2010
Rottapharm SpA - Discontinued Pipeline Products, 2010
Rottapharm SpA, Other Locations
Rottapharm SpA, Deals Summary, 2004 to 2011

List of Figures
Rottapharm SpA – Pipeline by Therapy Area and Indication, 2011
Rottapharm SpA – Pipeline by Stage of Development, 2011
Rottapharm SpA – Monotherapy Products in Pipeline, 2011
Rottapharm SpA – Pipeline By Therapeutic Class, 2011
Rottapharm SpA - Pipeline By Target, 2011
Rottapharm SpA – Pipeline By Route of Administration, 2011
Rottapharm SpA – Pipeline By Molecule Type, 2011

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos